6-amino-4-(ethoxycarbonyl)-5-methylpyrimidine-2-carboxaldehyde | 147911-87-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 6-amino-4-(ethoxycarbonyl)-5-methylpyrimidine-2-carboxaldehyde
• 英文别名: 4-amino-6-carboethoxy-5-methylpyrimidine-2-carboxaldehyde；Ethyl 6-amino-2-formyl-5-methylpyrimidine-4-carboxylate
• CAS: 147911-87-3
• 化学式: C₉H₁₁N₃O₃
• 分子量: 209.205
• InChiKey: GDQSLUUIKLPQTI-UHFFFAOYSA-N

物化性质

• 沸点：
  437.4±55.0 °C(Predicted)
• 密度：
  1.303±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  95.2
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  6-amino-4-(ethoxycarbonyl)-5-methylpyrimidine-2-carboxaldehyde 在 迭氮酸 、 偶氮二异丁腈 、 三氟甲磺酸二丁硼 、 三正丁基氢锡 、 N,N-二异丙基乙胺 、 三苯基膦 、 偶氮二甲酸二乙酯 作用下， 以 四氢呋喃 、 苯 为溶剂， 反应 21.0h， 生成 ethyl 2-<1(R)-azido-2-<((4S,5R)-4-methyl-5-phenyl-2-oxazolidinyl)carbonyl>ethyl>-6-amino-5-methylpyrimidine-4-carboxylate
  参考文献：
  名称：

  Total Synthesis of Bleomycin A2 and Related Agents. 2. Synthesis of (-)-Pyrimidoblamic Acid, epi-(+)-Pyrimidoblamic Acid, (+)-Desacetamidopyrimidoblamic Acid, and (-)-Descarboxamidopyrimidoblamic Acid

  摘要：

  Full details of concise syntheses of (-)-pyrimidoblamic acid (1), the authentic heterocyclic core of the bleomycin A(2) metal binding domain, as well as the key substructure analogs epi-(+)-pyrimidoblamic acid (2), (+)-desacetamidopyrimidoblamic acid (3), and (-)-descarboxamidppyrimidoblamic acid (4) are described. Key to the approach is the implementation of an inverse electron demand [4 + 2] cycloaddition reaction of 2,4,6-tris(ethoxycarbonyl)-1,3,5-triazine with 1-(dibenzylamino)-1-propyne or in situ generated 1,1-diaminopropene for the one-step preparation of an appropriately functionalized pyrimidine nucleus. The development and subsequent implementation of a diastereoselective imine addition reaction of optically active N-acyloxazolidinone enolates provided a stereocontrolled introduction of the pyrimidoblamic acid C2 acetamido side chain. Chemical studies which unambiguously establish and confirm the absolute configuration of the C2 acetamido side chain are detailed, and their extension to the synthesis of (-)-descarboxamidopyrimidoblamic acid (4) is described.

  DOI：

  10.1021/ja00092a012
• 作为产物：
  描述：

  1,3,5-三嗪-2,4,6-三甲酸三乙酯 在 manganese(IV) oxide 、 sodium tetrahydroborate 、 三氟甲磺酸 作用下， 以 1,4-二氧六环 、 乙醇 、 二氯甲烷 、 乙腈 为溶剂， 反应 52.0h， 生成 6-amino-4-(ethoxycarbonyl)-5-methylpyrimidine-2-carboxaldehyde
  参考文献：
  名称：

  Total Synthesis of Bleomycin A2 and Related Agents. 2. Synthesis of (-)-Pyrimidoblamic Acid, epi-(+)-Pyrimidoblamic Acid, (+)-Desacetamidopyrimidoblamic Acid, and (-)-Descarboxamidopyrimidoblamic Acid

  摘要：

  Full details of concise syntheses of (-)-pyrimidoblamic acid (1), the authentic heterocyclic core of the bleomycin A(2) metal binding domain, as well as the key substructure analogs epi-(+)-pyrimidoblamic acid (2), (+)-desacetamidopyrimidoblamic acid (3), and (-)-descarboxamidppyrimidoblamic acid (4) are described. Key to the approach is the implementation of an inverse electron demand [4 + 2] cycloaddition reaction of 2,4,6-tris(ethoxycarbonyl)-1,3,5-triazine with 1-(dibenzylamino)-1-propyne or in situ generated 1,1-diaminopropene for the one-step preparation of an appropriately functionalized pyrimidine nucleus. The development and subsequent implementation of a diastereoselective imine addition reaction of optically active N-acyloxazolidinone enolates provided a stereocontrolled introduction of the pyrimidoblamic acid C2 acetamido side chain. Chemical studies which unambiguously establish and confirm the absolute configuration of the C2 acetamido side chain are detailed, and their extension to the synthesis of (-)-descarboxamidopyrimidoblamic acid (4) is described.

  DOI：

  10.1021/ja00092a012

文献信息

• Total Synthesis of Deamido Bleomycin A₂, the Major Catabolite of the Antitumor Agent Bleomycin
  作者：Ying Zou、Nour Eddine Fahmi、Corine Vialas、Guy M. Miller、Sidney M. Hecht

  DOI：10.1021/ja012741l

  日期：2002.8.1

  and (1)H NMR spectroscopy. Deamido bleomycin A(2) was found to retain significant DNA cleavage activity in DNA plasmid relaxation assays and had the same sequence selectivity of DNA cleavage as bleomycin A(2). The most significant alteration of function noted in this study was a reduction in the ability of deamido bleomycin A(2) to mediate double-strand DNA cleavage, relative to that produced by BLM

  抗肿瘤抗生素博来霉素的代谢失活被认为仅通过博来霉素水解酶的作用介导，博来霉素水解酶是一种在自然界中广泛分布的半胱氨酸蛋白酶。虽然博来霉素表现出的抗肿瘤活性谱被认为反映了博来霉素水解酶在宿主体内的解剖分布，但很少有人在化学或生化水平上表征推定失活的产物。本报告描述了 deamidobleomycin demethyl A(2) (3) 和 deamido bleomycin A(2) (4) 的合成，以及各自的苷元。这些化合物都可以通过关键中间体 N(alpha)-Boc-N(beta)-[1-amino-3(S)-(4-amino-6-carboxy-5-methylpyrimidin-2-yl)propion- 3-基]-(S)-β-氨基丙氨酸叔丁酯(16)。合成 deamido 博来霉素 A(2) 显示与博来霉素 A(2) 与人博来霉素水解酶处理形成的产品相同，如反相 HPLC 分析和
• Boger, Dale L.; Menezes, Royce F.; Honda, Takeshi, Angewandte Chemie, 1993, vol. 105, # 2, p. 310 - 311
  作者：Boger, Dale L.、Menezes, Royce F.、Honda, Takeshi

  DOI：——

  日期：——

表征谱图